{
  "DOI": "10.1007/s00439-006-0142-0",
  "ISSN": [
    "0340-6717",
    "1432-1203"
  ],
  "URL": "http://dx.doi.org/10.1007/s00439-006-0142-0",
  "alternative-id": [
    "142"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Fitzgerald",
      "given": "Sara M.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Goyal",
      "given": "Rakesh K.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Osborne",
      "given": "William R. A.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Roy",
      "given": "Jennifer D.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wilson",
      "given": "John W.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ferrell",
      "given": "R. E.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2006,
        1,
        30
      ]
    ],
    "date-time": "2006-01-30T14:25:21Z",
    "timestamp": 1138631121000
  },
  "deposited": {
    "date-parts": [
      [
        2020,
        4,
        12
      ]
    ],
    "date-time": "2020-04-12T11:21:10Z",
    "timestamp": 1586690470000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        30
      ]
    ],
    "date-time": "2024-03-30T09:03:36Z",
    "timestamp": 1711789416692
  },
  "is-referenced-by-count": 53,
  "issn-type": [
    {
      "type": "print",
      "value": "0340-6717"
    },
    {
      "type": "electronic",
      "value": "1432-1203"
    }
  ],
  "issue": "3",
  "issued": {
    "date-parts": [
      [
        2006,
        1,
        31
      ]
    ]
  },
  "journal-issue": {
    "issue": "3",
    "published-print": {
      "date-parts": [
        [
          2006,
          4
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2006,
            1,
            31
          ]
        ],
        "date-time": "2006-01-31T00:00:00Z",
        "timestamp": 1138665600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s00439-006-0142-0.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s00439-006-0142-0/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s00439-006-0142-0",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "276-283",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2006,
        1,
        31
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2006,
        1,
        31
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2006,
        4
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "key": "142_CR1",
      "unstructured": "American Cancer Society (2004) Cancer facts and figures. http://www.cancer.org"
    },
    {
      "DOI": "10.1046/j.1365-2141.2000.02063.x",
      "author": "RJ Arceci",
      "doi-asserted-by": "crossref",
      "first-page": "285",
      "journal-title": "Br J Haematol",
      "key": "142_CR2",
      "unstructured": "Arceci RJ (2000) Can multidrug resistance mechanisms be modified? Br J Haematol 110:285–291",
      "volume": "110",
      "year": "2000"
    },
    {
      "DOI": "10.1006/jmbi.1994.1018",
      "author": "L Betts",
      "doi-asserted-by": "crossref",
      "first-page": "635",
      "journal-title": "J Mol Biol",
      "key": "142_CR3",
      "unstructured": "Betts L, Xiang S, Short SA, Wolfenden R, Carter CW Jr (1994) Cytidine deaminase. The 2.3 A crystal structure of an enzyme: transition-state analog complex. J Mol Biol 235:635–656",
      "volume": "235",
      "year": "1994"
    },
    {
      "DOI": "10.1016/0003-9861(91)90543-R",
      "author": "T Cacciamani",
      "doi-asserted-by": "crossref",
      "first-page": "285",
      "journal-title": "Arch Biochem Biophys",
      "key": "142_CR4",
      "unstructured": "Cacciamani T, Vita A, Cristalli G, Vincinzetti S, Natalini P, Ruggieri S, Magni G (1991) Purification of human cytidine deaminase: molecular and enzymatic characterization and inhibition by synthetic pyrimidine analogs. Arch Biochem Biophys 290:285–292",
      "volume": "290",
      "year": "1991"
    },
    {
      "author": "B Chabner",
      "first-page": "152",
      "key": "142_CR5",
      "unstructured": "Chabner B (1990) Cytidine analogs. In: Chabner BA, Collins JM (eds) Cancer chemotherapy: principals and practice. JB Lippincott, New York, pp 152–179",
      "volume-title": "Cancer chemotherapy: principals and practice",
      "year": "1990"
    },
    {
      "author": "LP Colly",
      "first-page": "257",
      "issue": "Suppl 1",
      "journal-title": "Semin Oncol",
      "key": "142_CR6",
      "unstructured": "Colly LP, Peters WG, Richel D, Arentsen-Honders MW, Starrenburg CW, Willemze R (1987) Deoxycytidine kinase and deoxycytidine deaminase values correspond closely to clinical response to cytosine arabinoside remission induction therapy in patients with acute myelogenous leukemia. Semin Oncol 14(Suppl 1):257–261",
      "volume": "14",
      "year": "1987"
    },
    {
      "DOI": "10.1007/BF00686248",
      "author": "LM DeAngelis",
      "doi-asserted-by": "crossref",
      "first-page": "173",
      "journal-title": "Cancer Chemother Pharmacol",
      "key": "142_CR7",
      "unstructured": "DeAngelis LM, Kreis W, Chan K, Dantis E, Akerman S (1992) Pharmacokinetics of ara-C and ara-U in plasma and CSF after high-dose administration of cytosine arabinoside. Cancer Chemother Pharmacol 29:173–177",
      "volume": "29",
      "year": "1992"
    },
    {
      "author": "S Demontis",
      "first-page": "323",
      "journal-title": "Biochem Biophys Acta",
      "key": "142_CR8",
      "unstructured": "Demontis S, Terao M, Brivio M, Zanotta S, Bruschi M, Garattini E (1998) Isolation and characterization of the gene coding for human cytidine deaminase. Biochem Biophys Acta 1443:323–333",
      "volume": "1443",
      "year": "1998"
    },
    {
      "DOI": "10.1038/sj.tpj.6500259",
      "author": "AK Fukunaga",
      "doi-asserted-by": "crossref",
      "first-page": "307",
      "journal-title": "Pharmacogenomics J",
      "key": "142_CR9",
      "unstructured": "Fukunaga AK, Marsh S, Murry DJ, Hurley TD, McLeod HL (2004) Identification and analysis of single-nucleotide polymorphisms in the gemcitabine pharmacologic pathway. Pharmacogenomics J 4:307–314",
      "volume": "4",
      "year": "2004"
    },
    {
      "DOI": "10.1038/sj.leu.2402114",
      "author": "CM Galmarini",
      "doi-asserted-by": "crossref",
      "first-page": "875",
      "journal-title": "Leukemia",
      "key": "142_CR10",
      "unstructured": "Galmarini CM, Mackey JR, Dumontet C (2001) Nucleoside analogues: mechanisms of drug resistance and reversal strategies. Leukemia 15:875–890",
      "volume": "15",
      "year": "2001"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-03-2456",
      "author": "Y Ge",
      "doi-asserted-by": "crossref",
      "first-page": "728",
      "journal-title": "Cancer Res",
      "key": "142_CR11",
      "unstructured": "Ge Y, Jensen TL, Stout ML, Flatley RM, Grohar PJ, Ravindranath V et al. (2004) The role of cytodine deaminase and GATA1 mutations in the increased cytosine arabinoside sensitivity of Down Syndrome myoblasts and leukemia cell lines. Cancer Res 64:728–735",
      "volume": "64",
      "year": "2004"
    },
    {
      "DOI": "10.1182/blood.V91.11.4127",
      "author": "C Gran",
      "doi-asserted-by": "crossref",
      "first-page": "4127",
      "journal-title": "Blood",
      "key": "142_CR12",
      "unstructured": "Gran C, Boyum A, Johansen RF, Lovhaug D, Seeberg EC (1998) Growth inhibition of granulocyte-macrophage colony-forming cells by human cytidine deaminase requires the catalytic function of the protein. Blood 91:4127–4135",
      "volume": "91",
      "year": "1998"
    },
    {
      "DOI": "10.1002/cpt1971126944",
      "author": "DH Ho",
      "doi-asserted-by": "crossref",
      "first-page": "944",
      "journal-title": "Clin Pharmacol Ther",
      "key": "142_CR13",
      "unstructured": "Ho DH, Frei E (1971) Clinical pharmacology of 1-beta-d-arabinofuranosyl cytosine. Clin Pharmacol Ther 12:944–954",
      "volume": "12",
      "year": "1971"
    },
    {
      "DOI": "10.1182/blood.V90.5.1968",
      "author": "G Jahns-Streubel",
      "doi-asserted-by": "crossref",
      "first-page": "1968",
      "journal-title": "Blood",
      "key": "142_CR14",
      "unstructured": "Jahns-Streubel G, Reuter C, Auf der Landwehr U, Unterhalt M, Schleyer E, Warmann B, Buckner T, Hiddemann W (1997) Activity of thymidine kinase and of polymerase alpha as well as activity and gene expression of deoxycytidine deaminase in leukemic blasts are correlated with clinical response in the setting of granulocyte-macrophage colony-stimulating factor-based priming before and during TAD-9 induction therapy in acute myeloid leukemia. Blood 90:1968–1976",
      "volume": "90",
      "year": "1997"
    },
    {
      "author": "HC Kirch",
      "first-page": "421",
      "journal-title": "Exp Hematol",
      "key": "142_CR15",
      "unstructured": "Kirch HC, Schroder J, Hoppe H, Esche H, Seeber S, Schutte J (1998) Recombinant gene products of two natural variants of the human cytidine deaminase gene confer different deamination rates of cytarabine in vitro. Exp Hematol 26:421–425",
      "volume": "26",
      "year": "1998"
    },
    {
      "DOI": "10.1006/bbrc.1993.1001",
      "author": "K Kuhn",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "journal-title": "Biochem Biophys Res Commun",
      "key": "142_CR16",
      "unstructured": "Kuhn K, Bertling WM, Emmrich F (1993) Cloning of a functional cDNA for human cytidine deaminase (CDD) and its use as a marker of monocyte/macrophage differentiation. Biochem Biophys Res Commun 190:1–7",
      "volume": "190",
      "year": "1993"
    },
    {
      "author": "J Laliberte",
      "first-page": "5401",
      "journal-title": "Cancer Res",
      "key": "142_CR17",
      "unstructured": "Laliberte J, Momparler RL (1994) Human cytidine deaminase: purification of enzyme, cloning, and expression of its complementary DNA. Cancer Res 54:5401–5407",
      "volume": "54",
      "year": "1994"
    },
    {
      "author": "RL Momparler",
      "first-page": "331",
      "journal-title": "Cancer Gene Ther",
      "key": "142_CR18",
      "unstructured": "Momparler RL, Eliopoulos N, Bovenzi V, Letourneau S, Greenbaum M, Cournoyer D (1996) Resistance to cytosine arabinoside by retrovirally mediated gene transfer of human cytidine deaminase into murine fibroblast and hematopoietic cells. Cancer Gene Ther 3:331–338",
      "volume": "3",
      "year": "1996"
    },
    {
      "author": "WE Muller",
      "first-page": "1102",
      "journal-title": "Cancer Res",
      "key": "142_CR19",
      "unstructured": "Muller WE, Zahn RK (1979) Metabolism of 1-beta-D-arabinofuranosyluracil in mouse L5178Y cells. Cancer Res 39:1102–1107",
      "volume": "39",
      "year": "1979"
    },
    {
      "author": "T Neff",
      "first-page": "1340",
      "journal-title": "Exp Hematol",
      "key": "142_CR20",
      "unstructured": "Neff T, Blau CA (1996) Forced expression of cytidine deaminase confers resistance to cytosine arabinoside and gemcitabine. Exp Hematol 24:1340–1346",
      "volume": "24",
      "year": "1996"
    },
    {
      "author": "N Onetto",
      "first-page": "231",
      "issue": "Suppl 1",
      "journal-title": "Semin Oncol",
      "key": "142_CR21",
      "unstructured": "Onetto N, Momparler RL, Momparler LF, Gyger M (1987) In vitro biochemical tests to evaluate the response to therapy of acute leukemia with cytosine arabinoside or 5-AZA-2′-deoxycytidine. Semin Oncol 14(Suppl 1):231–237",
      "volume": "14",
      "year": "1987"
    },
    {
      "DOI": "10.1073/pnas.85.18.6851",
      "author": "WRA Osborne",
      "doi-asserted-by": "crossref",
      "first-page": "6851",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "142_CR22",
      "unstructured": "Osborne WRA, Miller AD (1988) Design of vectors for efficient expression of human purine nucleoside phosphorylase in skin fibroblasts from enzyme-deficient humans. Proc Natl Acad Sci USA 85:6851–6855",
      "volume": "85",
      "year": "1988"
    },
    {
      "DOI": "10.1089/hum.1990.1.1-31",
      "author": "WRA Osborne",
      "doi-asserted-by": "crossref",
      "first-page": "31",
      "journal-title": "Hum Gene Ther",
      "key": "142_CR23",
      "unstructured": "Osborne WRA, Hock RA, Kaleko M, Miller AD (1990) Long-term expression of human adenosine deaminase in mice after transplantation of bone marrow infected with amphotropic retroviral vectors. Hum Gene Ther 1:31–41",
      "volume": "1",
      "year": "1990"
    },
    {
      "author": "JK Schroder",
      "first-page": "1919",
      "journal-title": "Leukemia",
      "key": "142_CR24",
      "unstructured": "Schroder JK, Kirch C, Flasshove M, Kalvert H, Seidelmann M, Hilger R, Seeber S, Schutte J (1996) Constitutive overexpression of the cytidine deaminase gene confers resistance to cytosine arabinoside in vitro. Leukemia 10:1919–1924",
      "volume": "10",
      "year": "1996"
    },
    {
      "DOI": "10.1046/j.1365-2141.1998.01084.x",
      "author": "JK Schroder",
      "doi-asserted-by": "crossref",
      "first-page": "1096",
      "journal-title": "Br J Haematol",
      "key": "142_CR25",
      "unstructured": "Schroder JK, Kirch C, Seeber S, Schutte J (1998) Structural and functional analysis of the cytidine deaminase gene in patients with acute myeloid leukaemia. Br J Haematol 103:1096–1103",
      "volume": "103",
      "year": "1998"
    },
    {
      "DOI": "10.1016/0014-2964(76)90164-X",
      "author": "JF Smyth",
      "doi-asserted-by": "crossref",
      "first-page": "567",
      "journal-title": "Eur J Cancer",
      "key": "142_CR26",
      "unstructured": "Smyth JF, Robins AB, Leese CL (1976) The metabolism of cytosine arabinoside as a predictive test for clinical response to the drug in acute myeloid leukaemia. Eur J Cancer 12:567–573",
      "volume": "12",
      "year": "1976"
    },
    {
      "DOI": "10.1038/newbio233109a0",
      "author": "CD Steuart",
      "doi-asserted-by": "crossref",
      "first-page": "109",
      "journal-title": "Nat New Biol",
      "key": "142_CR27",
      "unstructured": "Steuart CD, Burke PJ (1971) Cytidine deaminase and the development of resistance to arabinosyl cytosine. Nat New Biol 233:109–110",
      "volume": "233",
      "year": "1971"
    },
    {
      "DOI": "10.1111/j.1365-2141.1974.tb06772.x",
      "author": "MH Tattersall",
      "doi-asserted-by": "crossref",
      "first-page": "39",
      "journal-title": "Br J Haematol",
      "key": "142_CR29",
      "unstructured": "Tattersall MH, Ganeshaguru K, Hoffbrand AV (1974) Mechanisms of resistance of human acute leukaemia cells to cytosine arabinoside. Br J Haematol 27:39–46",
      "volume": "27",
      "year": "1974"
    },
    {
      "DOI": "10.1006/prep.1996.0097",
      "author": "S Vincenzetti",
      "doi-asserted-by": "crossref",
      "first-page": "247",
      "journal-title": "Protein Expr Purif",
      "key": "142_CR30",
      "unstructured": "Vincenzetti S, Cambi A, Neuhard J, Garattini E, Vita A (1996) Recombinant human cytidine deaminase: expression, purification, and characterization. Protein Expr Purif 8:247–253",
      "volume": "8",
      "year": "1996"
    },
    {
      "DOI": "10.1016/0167-4889(96)00024-9",
      "author": "S Watanabe",
      "doi-asserted-by": "crossref",
      "first-page": "99",
      "journal-title": "Biochim Biophys Acta",
      "key": "142_CR31",
      "unstructured": "Watanabe S, Uchida T (1996) Expression of cytidine deaminase in human solid tumors and its regulation by 1 alpha,25-dihydroxyvitamin D3. Biochim Biophys Acta 1312:99–104",
      "volume": "1312",
      "year": "1996"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-04-1497",
      "author": "K Yonemori",
      "doi-asserted-by": "crossref",
      "first-page": "2620",
      "journal-title": "Clin Cancer Res",
      "key": "142_CR32",
      "unstructured": "Yonemori K, Ueno H, Okusaka T, Yamamoto N, Ikeda M et al (2005) Severe drug toxicity associated with a single-nucleotide polymorphism of the cytidine deaminase gene in a Japanese cancer patient treated with gemcitabine plus cisplatin. Clin Cancer Res 11:2620–2624",
      "volume": "11",
      "year": "2005"
    },
    {
      "DOI": "10.1097/00008571-200301000-00005",
      "author": "L Yue",
      "doi-asserted-by": "crossref",
      "first-page": "29",
      "journal-title": "Pharmacogenetics",
      "key": "142_CR33",
      "unstructured": "Yue L, Saikawa Y, Ota K, Tanaka M, Uehara T, Maeba H (2003) A functional single-nucleotide polymorphism in the human cytidine deaminase gene contributing to ara-C sensitivity. Pharmacogenetics 13:29–38",
      "volume": "13",
      "year": "2003"
    },
    {
      "DOI": "10.1006/bbrc.1995.1069",
      "author": "K Yusa",
      "doi-asserted-by": "crossref",
      "first-page": "486",
      "journal-title": "Biochem Biophys Res Commun",
      "key": "142_CR34",
      "unstructured": "Yusa K, Oh-hara T, Tsuruo T (1995) Induction of resistance to 1-beta-D-arabinofuranosylcytosine in human H9 cell line by simian immunodeficiency virus. Biochem Biophys Res Commun 206:486–491",
      "volume": "206",
      "year": "1995"
    }
  ],
  "reference-count": 33,
  "references-count": 33,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s00439-006-0142-0"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Identification of functional single nucleotide polymorphism haplotypes in the cytidine deaminase promoter"
  ],
  "type": "journal-article",
  "volume": "119"
}